Category: Clinical
SJiMB21: A molecular path to treating infants with medulloblastoma
| May 18, 2023At St. Jude, clinical trial SJiMB21 seeks to provide treatment strategies for infants and young children diagnosed with medulloblastoma that place the patient, not just the tumor, at the center of care.
Learn moreResearch adds to understanding of AYA patients
| Apr 6, 2023Psychological, social and behavioral research sheds light on the needs of adolescents and young adults with cancer.
Learn moreDiagnostic Imaging receives hospital’s first Expanded Access use designation from FDA
| Dec 29, 2022St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.
Learn moreSt. Jude advice to young adults with sickle cell disease: Stay connected
| Nov 28, 2022The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.
Learn moreStudies of rare craniopharyngioma reveal ways to improve long-term outcomes for patients
| Nov 15, 2022A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.
Learn moreLatin American hospitals implement tool to identify kids whose condition is deteriorating
| Nov 1, 2022Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.
Learn moreSAFER Ukraine: a framework for responding to global conflicts
| May 26, 2022What lessons can be learned from the remarkable success of SAFER Ukraine?
Learn moreFive years later: gene therapy for ‘bubble boy’ disease
| May 19, 2022Interim results point to enduring immune function following gene therapy for Infants with ‘bubble boy’ disease
Learn moreReflecting on nearly 40 years of progress against pediatric brain tumors
| May 16, 2022May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.
Learn moreThe double-edged sword of being both parent and blood stem cell donor
| Mar 8, 2022What are the potential psychological and emotional risks and rewards for parents who serve as their children’s bone marrow donors?
Learn more